Association of Toll-Like Receptor 4 Polymorphisms with Diabetic Foot Ulcers and Application of Artificial Neural Network in DFU Risk Assessment in Type 2 Diabetes Patients
暂无分享,去创建一个
N. Agrawal | Kanhaiya Kumar Singh | V. Singh | S. Gupta | Kiran Singh | Kanhaiya Singh | Kiran Singh | Vivek Kumar Singh | Neeraj K. Agrawal | Sanjeev K. Gupta
[1] R. Arkell,et al. The Influence of Flightless I on Toll-Like-Receptor-Mediated Inflammation in a Murine Model of Diabetic Wound Healing , 2013, BioMed research international.
[2] A. Kumar,et al. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit , 2010 .
[3] A. Krieg,et al. Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity , 2007, Immunological reviews.
[4] Helen Y Wang,et al. Toll-like receptors and immune regulation: implications for cancer therapy , 2008, Oncogene.
[5] U. Ghoshal,et al. Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. , 2007, Human immunology.
[6] Laurence Zitvogel,et al. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.
[7] T. Mogensen. Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses , 2009, Clinical Microbiology Reviews.
[8] Kanhaiya,et al. Differential Expression of Toll like Receptor 4 in Type 2 Diabetic Patients with Impaired Wound Healing , 2013 .
[9] G. Van den Berghe,et al. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit* , 2009, Critical care medicine.
[10] D. Schwartz,et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.
[11] J Gibson,et al. Lower limb amputation. , 2001, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[12] W. Jeffcoate,et al. Wound healing and treatments for people with diabetic foot ulcers , 2004, Diabetes/metabolism research and reviews.
[13] D. Postma,et al. Association of polymorphisms in the TLR4 gene with the risk of developing neutropenia in children with leukemia , 2011, Leukemia.
[14] A. Boulton,et al. The global burden of diabetic foot disease , 2005, The Lancet.
[15] A. Crispin,et al. The Role of Toll‐like Receptor 4 Asp299Gly and Thr399Ile Polymorphisms and CARD15/NOD2 Mutations in the Susceptibility and Phenotype of Crohn's Disease , 2005, Inflammatory bowel diseases.
[16] T. Spector,et al. Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes , 2011, BMC Medical Genetics.
[17] J. A. Nogueira-Machado,et al. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation , 2011, Expert opinion on therapeutic targets.
[18] S. Kim. A Functional Polymorphism of Toll-like Receptor 4 Gene Increases Risk of Gastric Carcinoma and Its Precursors. Gastroenterology 2007;132:905-12 , 2007 .
[19] M. Fenton,et al. Toll-like receptors: a family of pattern-recognition receptors in mammals , 2002, Genome Biology.
[20] M. Tsan,et al. Endotoxin Contamination in Recombinant Human Heat Shock Protein 70 (Hsp70) Preparation Is Responsible for the Induction of Tumor Necrosis Factor α Release by Murine Macrophages* , 2003, The Journal of Biological Chemistry.
[21] D. Postma,et al. Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease , 2012, PloS one.
[22] Choung-Soo Kim,et al. The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men. , 2009, Cancer genetics and cytogenetics.
[23] Antonio Abbate,et al. Atherothrombosis, inflammation, and diabetes. , 2003, Journal of the American College of Cardiology.
[24] P. Matzinger,et al. Danger signals: SOS to the immune system. , 2001, Current opinion in immunology.
[25] S. Akira,et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.
[26] R. Diegelmann,et al. Wound healing: an overview of acute, fibrotic and delayed healing. , 2004, Frontiers in bioscience : a journal and virtual library.
[27] R. Heshmat,et al. VEGF gene polymorphism association with diabetic foot ulcer. , 2011, Diabetes research and clinical practice.
[28] B. Isermann,et al. Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes. , 2004, Diabetes care.
[29] J. Weiss,et al. Expression of Functional D299G.T399I Polymorphic Variant of TLR4 Depends More on Coexpression of MD-2 Than Does Wild-Type TLR4 , 2010, The Journal of Immunology.
[30] J. Whitney. Overview: acute and chronic wounds. , 2005, The Nursing clinics of North America.
[31] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[32] M. Nolte,et al. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity , 2009, Immunological reviews.
[33] G. Barton,et al. A calculated response: control of inflammation by the innate immune system. , 2008, The Journal of clinical investigation.
[34] Geoffrey E. Hinton,et al. Learning internal representations by error propagation , 1986 .
[35] E. El-Omar,et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. , 2007, Gastroenterology.
[36] S. Devaraj,et al. Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects , 2010, Diabetes Care.
[37] L P Le Quesne,et al. The aetiology of diabetic neuropathic ulceration of the foot , 1985, The British journal of surgery.
[38] A. Scherag,et al. Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas , 2011, Journal of Translational Medicine.